Compliance Officer

• Sep 2018 - Present

Executive Director, Corporate Ethics and Compliance

• Jul 2015 - Jul 2018

Currently responsible for conduct and oversight of all aspects of Eisai's comprehensive Ethics and Compliance Program. Lead, guide and develop a team of 14 professionals responsible for implementing specific elements of Eisai's Compliance Program. Responsible for formal quarterly updates to the US Board of Directors and US Executive Committee. Represent US Ethics and Compliance at bi-annual, in-person global Corporate Officer Training and Corporate Global Compliance Committee at headquarters in Tokyo. Oversee the provision of Ethics and Compliance support and guidance to, and coordination with, Eisai network companies in Canada, Brazil and Mexico. Liaison, partner and coordinate with colleagues outside of the US to implement global policies or address cross-border issues; e.g., FCPA, UK Bribery Act, US federal transparency reporting, EFPIA transparency reporting, GDPR. Senior Director – Corporate Ethics and Compliance January 2013 – July 2015 Responsible for oversight and direction of the US Compliance Program for Eisai Inc. as well as supervising and directing the Healthcare Compliance team, including: Policy, Training, Monitoring, Organization and Management. Initiated the role of “business partner” and aligned compliance professionals with business units to foster relationships and raise awareness of compliance principles throughout the business planning and execution process and built a strong team oriented culture leading to enhanced collaboration between the various functions.

Director, Regulatory Compliance

• Jul 2008 - Jan 2013

Novartis Pharmaceuticals Corporation, East Hanover, NJDirector – Risk Management April 2012 - January 2013Responsible for policy management, creation, editing and ensuring compliance advisor alignment across four business units. Provide compliance and event oversight expertise in support of Governance Board oversight model including initial and ongoing training of Governance Board members and continued oversight of Governance Board activities to ensure consistency across business units.Director – Regulatory Compliance August 2008 – March 2012Responsible for ensuring adherence to all policy language requirements for CIA implementation; including, sales targeting alignment and the development of call plans, sales incentive planning, promotional materials review submission guidelines, samples distribution and tracking, ensuring policy related to promotional functions complied with all FDA and federal healthcare program requirements, the role and manner of medical affairs personnel interactions with HCPs, and training and education of sales representatives.Chair, Conflict of Interest CommitteeChair, Events Oversight CommitteeChair, Business Policy CommitteeBusiness Unit Advisor to the Neuro/Psychiatric Business Unit sales and marketingManage and Supervise state law and aggregate spend reporting and compliance functions

Director, Medical Information

• Apr 2002 - Jul 2008